MSF Access
@msfaccess.org
Today is World Diabetes Day.
More than 800 million people have diabetes, most of whom live in low- and middle-income countries.
For people w/ type 1 diabetes, insulin is lifesaving, but it's often unavailable in low-resource and emergency settings and unaffordable elsewhere.
More than 800 million people have diabetes, most of whom live in low- and middle-income countries.
For people w/ type 1 diabetes, insulin is lifesaving, but it's often unavailable in low-resource and emergency settings and unaffordable elsewhere.
November 14, 2025 at 11:14 AM
Today is World Diabetes Day.
More than 800 million people have diabetes, most of whom live in low- and middle-income countries.
For people w/ type 1 diabetes, insulin is lifesaving, but it's often unavailable in low-resource and emergency settings and unaffordable elsewhere.
More than 800 million people have diabetes, most of whom live in low- and middle-income countries.
For people w/ type 1 diabetes, insulin is lifesaving, but it's often unavailable in low-resource and emergency settings and unaffordable elsewhere.
Lecritia, from South Africa, is comfortable using insulin pens.
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
November 14, 2025 at 11:08 AM
Lecritia, from South Africa, is comfortable using insulin pens.
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
Scientists discovered insulin over 100 years ago, envisioning a world where everyone could access #diabetes treatment.
But it is often unavailable or unaffordable.
Ahead of World Diabetes Day tomorrow, we’re calling for affordable & available insulin pens for all.
But it is often unavailable or unaffordable.
Ahead of World Diabetes Day tomorrow, we’re calling for affordable & available insulin pens for all.
November 13, 2025 at 6:16 PM
Scientists discovered insulin over 100 years ago, envisioning a world where everyone could access #diabetes treatment.
But it is often unavailable or unaffordable.
Ahead of World Diabetes Day tomorrow, we’re calling for affordable & available insulin pens for all.
But it is often unavailable or unaffordable.
Ahead of World Diabetes Day tomorrow, we’re calling for affordable & available insulin pens for all.
Today @who.int released their 2025 #tuberculosis report, and figures remain unacceptable: 1.2 million children and young adolescents fell ill in 2024, and a staggering 43% were never diagnosed and thus missed lifesaving treatment. Act now to close the deadly gap!
msfaccess.org/msf-responds...
msfaccess.org/msf-responds...
November 12, 2025 at 3:22 PM
Today @who.int released their 2025 #tuberculosis report, and figures remain unacceptable: 1.2 million children and young adolescents fell ill in 2024, and a staggering 43% were never diagnosed and thus missed lifesaving treatment. Act now to close the deadly gap!
msfaccess.org/msf-responds...
msfaccess.org/msf-responds...
🦠 It's estimated that by 2050, antibiotic resistance will cause 8.22 million deaths per year.
To try and combat this, MSF launched Antibiogo, a free diagnostic aid app to combat antibiotic resistance by improving access to patient diagnoses.
Learn more:
To try and combat this, MSF launched Antibiogo, a free diagnostic aid app to combat antibiotic resistance by improving access to patient diagnoses.
Learn more:
October 24, 2025 at 4:03 PM
🦠 It's estimated that by 2050, antibiotic resistance will cause 8.22 million deaths per year.
To try and combat this, MSF launched Antibiogo, a free diagnostic aid app to combat antibiotic resistance by improving access to patient diagnoses.
Learn more:
To try and combat this, MSF launched Antibiogo, a free diagnostic aid app to combat antibiotic resistance by improving access to patient diagnoses.
Learn more:
More than 800 million people have diabetes, the majority of whom live in low- and middle-income countries.
For people with type 1 diabetes, insulin is lifesaving, but it is often unavailable in low-resource and emergency settings, and unaffordable elsewhere.
For people with type 1 diabetes, insulin is lifesaving, but it is often unavailable in low-resource and emergency settings, and unaffordable elsewhere.
September 24, 2025 at 8:58 AM
More than 800 million people have diabetes, the majority of whom live in low- and middle-income countries.
For people with type 1 diabetes, insulin is lifesaving, but it is often unavailable in low-resource and emergency settings, and unaffordable elsewhere.
For people with type 1 diabetes, insulin is lifesaving, but it is often unavailable in low-resource and emergency settings, and unaffordable elsewhere.
“The main fear is just having those vials break.”
Lecritia, from South Africa, is comfortable using insulin pens.
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
Lecritia, from South Africa, is comfortable using insulin pens.
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
September 17, 2025 at 3:13 PM
“The main fear is just having those vials break.”
Lecritia, from South Africa, is comfortable using insulin pens.
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
Lecritia, from South Africa, is comfortable using insulin pens.
She reacted to possibly switching back to less convenient vials & syringes due to a decision by Novo Nordisk to discontinue human insulin pens (recorded in 2024).
In 2024, only 16% of children in the Central African Republic had completed their full vaccination schedule, while 34% had never received any vaccine.
In Batangafo health zone, we work with the Ministry of Health to close this gap, providing children with routine vaccinations.
In Batangafo health zone, we work with the Ministry of Health to close this gap, providing children with routine vaccinations.
September 12, 2025 at 4:23 PM
In 2024, only 16% of children in the Central African Republic had completed their full vaccination schedule, while 34% had never received any vaccine.
In Batangafo health zone, we work with the Ministry of Health to close this gap, providing children with routine vaccinations.
In Batangafo health zone, we work with the Ministry of Health to close this gap, providing children with routine vaccinations.
In 2024, only 16% of children in the Central African Republic had completed their full vaccination schedule, while 34% had never received any vaccine.
In Batangafo health zone, we work with the Ministry of Health to close this gap, providing children with routine vaccinations.
In Batangafo health zone, we work with the Ministry of Health to close this gap, providing children with routine vaccinations.
September 12, 2025 at 4:21 PM
In 2024, only 16% of children in the Central African Republic had completed their full vaccination schedule, while 34% had never received any vaccine.
In Batangafo health zone, we work with the Ministry of Health to close this gap, providing children with routine vaccinations.
In Batangafo health zone, we work with the Ministry of Health to close this gap, providing children with routine vaccinations.
Insulin pens must be affordable and available for all people with #diabetes who need them.
Why? For many people with diabetes, using pens to administer insulin is easier, more accurate, and preferred over more difficult-to-use vials and syringes.
Why? For many people with diabetes, using pens to administer insulin is easier, more accurate, and preferred over more difficult-to-use vials and syringes.
June 13, 2025 at 1:50 PM
Insulin pens must be affordable and available for all people with #diabetes who need them.
Why? For many people with diabetes, using pens to administer insulin is easier, more accurate, and preferred over more difficult-to-use vials and syringes.
Why? For many people with diabetes, using pens to administer insulin is easier, more accurate, and preferred over more difficult-to-use vials and syringes.
Hey @novonordisk.bsky.social, all #insulin pens must be available at $1 per pen, so that everyone can access the highest standard of diabetes treatment, especially as their cost of production is estimated to be as low as $0.94 per pen, including a profit.
June 12, 2025 at 3:39 PM
Hey @novonordisk.bsky.social, all #insulin pens must be available at $1 per pen, so that everyone can access the highest standard of diabetes treatment, especially as their cost of production is estimated to be as low as $0.94 per pen, including a profit.